Past participants of this course consistently report that this program has inspired and improved their clinical practice and outcomes. Here are a few comments from recent attendees:
The opportunity to ask in-depth questions, and the ability of faculty to answer them on the spot, made this program extraordinarily valuable.
The truly up-to-date management options have changed my clinical decision making and therapy sequences in several areas.
I have begun to treat IBD more aggressively in my practice.
For UC patients in the hospital, I now use a higher dose of infliximab.
The attention given to polypectomy skills and measurement of quality in the GI lab were truly exceptional.
This course has taught me to use new endoscopic treatments (such as managing big colonic polyps) and how to deal with endoscopic complications.
After this course, I restart anticoagulation earlier in patients at high risk for thromboembolic disease.
This program encouraged me to incorporate a more thorough discussion with my patients pertaining to diagnosis and treatment, leading to better patient care.
In my practice, since attending this course, I have moved toward more liberal prescribing of psych meds, more focus on FODMAPs, and have altered my approach to starting/restarting biologics.
This conference provided me with numerous clinical pearls that are directly relevant to my daily practice.
I found the updates and clinical approaches for esophageal hypomotility to be very helpful. I have incorporated them into my practice.
You leave <this program> with a greater awareness and understanding of the options for treating hepatitis.
I have changed my screening intervals for Barrett’s.
My treatment of viral hepatitis is now current with state-of-the-art practices.
I have incorporated the course’s approach to the pancreatic mass and other recent advances like screening high-risk patients for pancreatic cancer.
I prescribe the evidence-based diets presented in this course for patients with different GI diseases.
My management of liver disease and IBD has been updated by this course.
I am more cognizant of ductal changes as harbingers of cholangiocarcinoma.
In my practice, I have added injection of epinephrine into the head of big polyps in addition to injection in the stalk and a PolyLoop.
The course did a remarkable job in presenting "advances in gastroenterology."
This course has led to many changes in my practice: I have started to consider laryngopharyngeal reflux in the differential of patients with seemingly no reflux symptoms; I prescribe aspirin more often in appropriate patients for chemoprevention of colorectal cancer; I do a better job of nutritional assessment of patients post-bariatric surgery; I perform a more thorough evaluation of NAFLD patients.
As a result of this program, I do a number of things differently. I am managing LPR differently. I look for inlet patches in ways I had not previously done. I certainly prescribe for IBS differently.
The presenters did a great job in discussing the clinical relevance of new drugs and treatments for many of the GI conditions – those I see frequently and occasionally in my practice. The updates were clinically relevant to my practice.